Vertex Pharmaceuticals Raises 2026 Revenue Guidance After Mixed Q3

The new range tops out below the $13.28 billion consensus estimate, as quarterly revenue beat estimates and the bottom-line result missed.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.